The Dopamine Hypothesis of Schizophrenia: An Historical and ...

62 ■ PPP / Vol. 18, No. 1 / March 2011
Kitcher, P. 1993. The advancement of science: Science
without legend, objectivity without illusions. New
York: Oxford University Press.
Kojima, H., O. Ohmori, T. Shinkai, T. Terao, et al.
1999. Dopamine D1 receptor gene polymorphism
and schizophrenia in Japan. American Journal of
Medical Genetics 88, no. 2:116–9.
Koob, G. F., and M. Le Moal. 2006. Psychostimulants.
In Neurobiology of addiction, ed. G. F. Koob, and
M. Le Moal, 69–120. London: Academic Press,
Elsevier, Inc.
Kopin, I. J. 1993. Parkinson’s disease: Past, present, and
future. Neuropsychopharmacology 9, no. 1:1–12.
Kuhn, T. S. 1996. The structure of scientific revolutions,
3rd ed. Chicago: University of Chicago Press.
Lacasse, J. R., and J. Leo. 2005. Serotonin and depression:
A disconnect between the advertisements and
the scientific literature. PLoS Med 2, no. 12:e392.
Lakatos, I. 1970. Falsification and the methodology of
scientific research programmes. In Criticism and the
growth of knowledge, ed. I. Lakatos, and A. Musgrave,
91–197. London: Cambridge University Press.
Laudan, L. 1977. Progress and its problems. Berkeley:
University of California Press.
Lieberman, J. A., J. M. Kane, and J. Alvir. 1987. Provocative
tests with psychostimulant drugs in schizophrenia.
Psychopharmacology 91:415–33.
Maas, J. W., S. A. Contreras, A. L. Miller, N. Berman,
et al. 1993. Studies of catecholamine metabolism in
schizophrenia/psychosis—I. Neuropsychopharmacology
8, no. 2:97–109.
Magee, B. 1982. Popper. London: Fontana Paperbacks.
Marx, C. E., and J. A. Lieberman. 1998. Psychoneuroendocrinology
of schizophrenia. Psychiatric Clinics
of North America 21, no. 2:413–34.
Matthysse, S. 1973. Antipsychotic drug actions—Clue
to neuropathology of schizophrenia. Federation
Proceedings 32, no. 2:200–5.
Matthysse, S., and J. Lipinski. 1975. Biochemical aspects
of schizophrenia. Annual Review of Medicine
26:551–65.
Meltzer, H. Y., and S. M. Stahl. 1976. The dopamine
hypothesis of schizophrenia: a review. Schizophrenia
Bulletin 2, no. 1:19–76.
Montagu, K. A. 1957. Catechol compounds in rat tissues
and in brains of different animals. Nature 180,
no. 4579:244–5.
Munafo, M. R., L. Bowes, T. G. Clark, and J. Flint.
2005. Lack of association of the COMT (Val158/108
Met) gene and schizophrenia: A meta-analysis of
case-control studies. Molecular Psychiatry 10, no.
8:765–70.
Owen, M. J., N. M. Williams, and M. C. O’Donovan.
2004. The molecular genetics of schizophrenia: New
findings promise new insights. Molecular Psychiatry
9, no. 1:14–27.
Pae, C. U., J. J. Kim, A. Serretti, C. U. Lee, et al. 2003.
VNTR polymorphism of tyrosine hydroxylase gene
and schizophrenia in the Korean population. Neuropsychobiology
47, no. 3:131–6.
Platt, J. R. 1964. Strong inference. Science 146, no.
3642: 347–53.
Popper, K. R. 1959. The logic of scientific discovery.
New York: Basic Books.
——–. 1962. Conjectures and refutations. New York:
Basic Books.
Predescu, V., D. Florescu, and C. Radulesc. 1968. Pink
spot as a diagnostic test in schizophrenia. Nature
217, no. 5134:1150.
Schaffner, K. F. 1992. Theory change in immunology.
2. The clonal selection theory. Theoretical Medicine
13, no. 2:175–216.
——–. 1993. Discovery and explanation in biology and
medicine. Chicago: The University of Chicago Press.
——–. 1994. Psychiatry and molecular biology:
Reductionistic approaches to schizophrenia in
philosophical perspectives on psychiatric diagnostic
classification. Baltimore, MD: The Johns Hopkins
University Press.
——–. 2002. Clinical and etiological psychiatric diagnoses:
Do causes count? In Descriptions and prescriptions:
Values, mental disorders, and the DSMs, ed.
J. Z. Sadler, 271–90. Baltimore, MD: The Johns
Hopkins University Press.
Seeman, P., T. Lee, M. Chauwong, and K. Wong. 1976.
Antipsychotic drug doses and neuroleptic-dopamine
receptors. Nature 261, no. 5562:717–9.
Shapere, D., and D. R. Dordrecht. 1984. Reason and
the search for knowledge: Investigations in the philosophy
of science (Boston studies in the philosophy
of science). Boston: D. Reidel Publishing Company.
Shifman, S., M. Bronstein, M. Sternfeld, A. Pisante-
Shalom, et al. 2002. A highly significant association
between a COMT haplotype and schizophrenia.
American Journal of Human Genetics 71, no.
6:1296–302.
Shorter, E. 1997. A history of psychiatry: From the era
of the asylum to the age of Prozac. New York: John
Wiley & Sons, Inc.
Skare, S. S., M. W. Dysken, and C. J. Billington. 1994.
A review of GHRH stimulation test in psychiatry.
Biological Psychiatry 36, no. 4:249–65.
Snyder, S. H. 1976. The dopamine hypothesis of schizophrenia:
Focus on the dopamine receptor. American
Journal of Psychiatry 133, no. 2:197–202.
Snyder, S. H., G. K. Aghajanian, and S. Matthysse.
1972. Prospects for research on schizophrenia. V.
Pharmacological observations, drug-induced psy-